Cellmid just cannot take a trick, can it?
Just when it announces two months ago that it is in negotiations with a buyer to divest Lyramid, along comes Covid and spoils everything.
And what have Cellmid/Lyramid been doing about Covid? They have just got OUT of the Covid antibody business. And now they watch Ellumehealth pocket 230 million dollars for going INTO the Covid antigen business.
Blooming Covid.
Life can be a beach.
Cellmid just cannot take a trick, can it?Just when it announces...
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1100000 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 580778 | 4 |
View Market Depth
| Last trade - 16.12pm 22/05/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable